EmStop, Inc.
PrivateLast Round
Seed
Apr 29, 2021
Company Overview
EmStop, Inc. is a cardiovascular medical device company that develops and commercializes integrated embolic protection systems for transcatheter aortic valve replacement (TAVR) and other left-heart catheterization procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
embolic protection systemEPSTAVRtranscatheter aortic valve replacementcardiovascular medical devicestroke preventioninterventional cardiologythrombus removalstructural heartcerebral protectionembolic filtercatheter-based proceduremedtechvascular intervention
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EmStop, Inc. Comparables
Compare EmStop, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emblok | 88% | |
| Protembis GmbH | 88% | |
| Emboline | 86% | |
EmStop, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 29, 2021 |
EmStop, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EmStop, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersMinneapolis, Minnesota
Employee Range4
Year Founded2021
Last FundingApr 29, 2021